The nitric oxide donor S-nitroso-N-acetylpenicillamine (SNAP) increases free radical generation and degrades left ventricular function after myocardial ischemia-reperfusion

Resuscitation

Volumn 59, Issue 3, 2003, Pages 345-352

  Zhang, Yi ^a   Davies, Loyd R ^a   Martin, Sean M ^a   Coddington, William J ^a   Miller Jr , Francis J ^a   Buettner, Garry R ^a   Kerber, Richard E ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Ascorbate; Free radicals; Ischemia; Nitric oxide; Reperfusion; S nitroso N acetylpenicillamine; Stunning

Indexed keywords

3 NITROTYROSINE; ASCORBIC ACID; FREE RADICAL; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CONVALESCENCE; CORONARY SINUS; DOG; DRUG INFUSION; ECHOCARDIOGRAPHY; ELECTRON SPIN RESONANCE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMMUNOHISTOCHEMISTRY; INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MONITORING; NONHUMAN; OXIDATION; PRIORITY JOURNAL; STAINING; THORAX;

EID: 0345059129     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(03)00240-5     Document Type: Article

References (39)

1. Hearse D.J., Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc. Res. 26:1992;101-108.
2. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc. Drugs Ther. 5:(Suppl. 2):1991;249-268.
3. Kramer J.H., Misik V., Weglicki M.B. Lipid peroxidation-derived free radical production and postischemic myocardial reperfusion injury. Ann. New York Acad. Sci. 723:1994;180-196.
4. Kukreja R.C., Hess M.L. The oxygen free radical system: from equations through membrane-protein interaction to cardiovascular injury and protection. Cardiovasc. Res. 26:1992;641-655.
5. Bolli R. Basic and clinical aspects of myocardial stunning. Prog. Cardiovasc. Dis. 40:1998;477-516.
6. Liaudet L., Soriano F.G., Szabo C. Biology of nitric oxide signaling. Crit. Care Med. 28:(Suppl.):2000;N37-N52.
7. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. New Engl. J. Med. 329:1993;2002-2012.
8. Wink D.A., Mitchell J.B. Chemical biology of nitric oxide: insights into regulatory cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25:1998;434-456.
9. Weyrich A.S., Ma X.L., Lefer A.M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 86:1992;279-288.
10. Shinmura K., Tang X.L., Takamo H., et al. Nitric oxide donors attenuate myocardial stunning in conscious rabbits. Am. J. Physiol. 277:1999;112495- 112503.
11. Sato H., Zhao Z.Q., McGee D., et al. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J. Thorac. Cardiovasc. Surg. 110:1995;302-314.
12. Amrani M., Chester A.H., Jayakumar J., et al. L-argininc reverses low coronary reflow and enhances postischemic recovery of cardiac mechanical function. Cardiovasc. Res. 30:1995;200-204.
13. Lefer A.M. Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy. Ann. Thorac. Surg. 60:1995;847-851.
14. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad and the ugly. Am. J. Physiol. 271:1996;C1424-C1437.
15. Muijsers R.B.R., Folkerts G., Henricks P.A.J., et al. Peroxynitrite: a two-faced metabolite of nitric oxide. Life Sci. 60:1997;1833-1845.
16. Yasmin W., Strynadka K., Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion in isolated rat hearts. Cardiovasc. Res. 33:1997;422-432.
17. G-nitro-L arginine improves myocardial function following ischemia/reperfusion in isolated perfused rate heart. J. Mol. Cell. Cardiol. 27:1995;419-426.
18. Zhang Y., Bissing J.W., Xu L., et al. Nitric oxide synthase inhibitors decrease coronary sinus-free radical concentration and ameliorate myocardial stunning in an ischemia-reperfusion model. J. Am. Coll. Cardiol. 38:2001;546-554.
19. Bolli R., Patel B.S., Jeroudi M.O., et al. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin α-phenyl-N-tertbutyl nitrone. J. Clin. Invest. 82:1988;476-485.
20. Baker J.E., Felix C.C., Olinger G.N., et al. Myocardial ischemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. Proc. Natl. Acad. Sci. USA. 85:1988;2786-2789.
21. Sharma M.K., Buettner G.R., Spencer K.T., et al. Aseorbyl free radical as a real-time marker of free radical generation in briefly ischemia and reperfusion hearts. An electron paramagnetic resonance study. Circ. Res. 74:1994;650-658.
22. Buettner G.R. The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300:1993;535-543.
23. Buettner G.R., Jurkiewiez B.A. Ascorbate free radical as a marker of oxidative stress: an EPR study. Free Radic. Biol. Med. 14:1993;49-55.
24. Buettner G.R., Kiminyo K.P. Optimal EPR detection of weak nitroxide spin adduct and ascorbate free radical signals. J. Biochem. Biophys. Methods. 24:1992;147-151.
25. SAS Institute. SAS/STAT Software: Changes and Enhancements through Release 6.11. Chap. 18. Cary, NC, SAS Institute, 1996;531-56.
26. Lindower P.D., Spencer K.T., Caterine M.R., et al. Prolonged coronary artery occlusion-reperfusion sequences reduce myocardial free radical production: an electron paramagnetic resonance study. Am. Heart J. 132:1996;1147-1155.
27. Garcia L.A., DeJong S.C., Martin S.M., et al. Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model. J. Am. Coll. Cardiol. 32:1998;536-539.
28. Caterine M.R., Spencer K.T., Pagan-Carlo L.A., et al. Direct current shocks to the heart generate free radicals: an electron paramagnetic resonance study. J. Am. Coll. Cardiol. 28:1996;1598-1609.
29. Nakanishi K., Vinten-Johansen J., Lefer D.J., et al. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am. J. Physiol. 263:1992;H1650-H1658.
30. Lefer D.J., Nakanishi K., Johnson W.E., et al. Antineutrophil and myocardial protection actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation. 88:1993;2337-2350.
31. Patel V.C., Yellon D.M., Singh K.J., et al. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem. Biophys. Res. 194:1993;234-238.
32. Woolfson R.G., Patel V.C., Neild G.H., et al. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation. 91:1995;1545-1551.
33. + channel opening property and nitrate property. Clin. Exp. Pharmacol. Physiol. 20:1993;595-602.
34. Gross G.J., Pieper G.M., Warltier D.C. Comparative effects of nicorandil, nitroglycerin, nicotinic acid: and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium. J. Cardiovasc. Pharmacol. 10:1987;S76-S84.
35. Hasebe N., Shen Y.T., Vatner S.F. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation. 88:1993;2862-2871.
36. Mori E., Haramaki N., Ikeda H., et al. Intracoronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs. Cardiovasc. Res. 40:1998;113-123.
37. Wang P., Zweier J.L. Measurement of nitric oxide and peroxynitrite generation in the postischemie heart: evidence for peroxynitrite-mediated reperfusion injury. J. Biol. Chem. 271:1996;29223-29230.
38. Liu P., Hock C.E., Nagele R., et al. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am. J. Physiol. 272:1997;H2327-H2336.
39. Takano H., Tang X.L., Qiu Y., et al. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ. Res. 83:1998;73-84.